ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gabapentin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-16D300
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Gabapentin Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Gabapentin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-16D300
Report
July 2025
Pages:173
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
TEVA
Mylan NV
Arbor Pharma
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Glenmark
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike
Assertio Therapeutics

Gabapentin Market Size

In 2024, the global market size of Gabapentin was estimated to be worth US$ 1598 million and is forecast to reach approximately US$ 1807 million by 2031 with a CAGR of 1.8% during the forecast period 2025-2031.

Gabapentin Market

Gabapentin Market

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
Global Gabapentin key players include Novartis, TEVA, Mylan, Pfizer, etc. Global top four manufacturers hold a share about 20%.
North America is the largest market, with a share over 30%, followed by Asia-Pacific, and Europe, both have a share about 50 percent.
In terms of product, Capsule is the largest segment, with a share about 55%. And in terms of application, the largest application is Epilepsy, followed by Neuropathic Pain, Restless Legs Syndrome, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gabapentin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gabapentin.
The Gabapentin market size, estimations, and forecasts are provided in terms of sales volume (M Unit) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gabapentin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gabapentin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Gabapentin Market Report

Report Metric Details
Report Name Gabapentin Market
Forecasted market size in 2031 approximately US$ 1807 million
CAGR 1.8%
Forecasted years 2025 - 2031
Segment by Type
  • Capsule
  • Tablet
Segment by Application
  • Epilepsy
  • Neuropathic Pain
  • Restless Legs Syndrome
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Assertio Therapeutics, TEVA, Mylan, Arbor Pharma, Novartis, Apotex, Sun Pharmaceutical, Aurobindo Pharma, Intas, Amneal, Marksans Pharma, Glenmark, Alkem, Jiangsu Enhua, Jiangsu Hengrui, Sailike
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Gabapentin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Gabapentin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gabapentin sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Gabapentin Market size in 2031?

Ans: The Gabapentin Market size in 2031 will be approximately US$ 1807 million.

What is the market share of major companies in Gabapentin Market?

Ans: Global top four manufacturers hold a share about 20%.

What is the Gabapentin Market share by type?

Ans: In terms of product, Capsule is the largest segment, with a share about 55%.

Who are the main players in the Gabapentin Market report?

Ans: The main players in the Gabapentin Market are Pfizer, Assertio Therapeutics, TEVA, Mylan, Arbor Pharma, Novartis, Apotex, Sun Pharmaceutical, Aurobindo Pharma, Intas, Amneal, Marksans Pharma, Glenmark, Alkem, Jiangsu Enhua, Jiangsu Hengrui, Sailike

What are the Application segmentation covered in the Gabapentin Market report?

Ans: The Applications covered in the Gabapentin Market report are Epilepsy, Neuropathic Pain, Restless Legs Syndrome, Others

What are the Type segmentation covered in the Gabapentin Market report?

Ans: The Types covered in the Gabapentin Market report are Capsule, Tablet

1 Study Coverage
1.1 Gabapentin Product Introduction
1.2 Market by Type
1.2.1 Global Gabapentin Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Capsule
1.2.3 Tablet
1.3 Market by Application
1.3.1 Global Gabapentin Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Epilepsy
1.3.3 Neuropathic Pain
1.3.4 Restless Legs Syndrome
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Gabapentin Market Size Estimates and Forecasts
2.1.1 Global Gabapentin Revenue 2020-2031
2.1.2 Global Gabapentin Sales 2020-2031
2.2 Gabapentin Market Size by Region: 2024 Versus 2031
2.3 Gabapentin Sales by Region (2020-2031)
2.3.1 Global Gabapentin Sales by Region: 2020-2025
2.3.2 Global Gabapentin Sales Forecast by Region (2026-2031)
2.3.3 Global Gabapentin Sales Market Share by Region (2020-2031)
2.4 Gabapentin Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Gabapentin Revenue by Region: 2020-2025
2.4.2 Global Gabapentin Revenue Forecast by Region (2026-2031)
2.4.3 Global Gabapentin Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Gabapentin Sales by Type (2020-2031)
3.1.1.1 Global Gabapentin Sales Volume by Type (2020-2031)
3.1.1.2 Global Gabapentin Sales Market Share by Type (2020-2031)
3.1.2 Global Gabapentin Revenue by Type (2020-2031)
3.1.2.1 Global Gabapentin Revenue by Type (2020-2031)
3.1.2.2 Global Gabapentin Revenue Market Share by Type (2020-2031)
3.1.3 Gabapentin Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Gabapentin Sales by Application (2020-2031)
3.2.1.1 Global Gabapentin Sales Volume by Application (2020-2031)
3.2.1.2 Global Gabapentin Sales Market Share by Application (2020-2031)
3.2.2 Global Gabapentin Revenue by Application (2020-2031)
3.2.2.1 Global Gabapentin Revenue by Application (2020-2031)
3.2.2.2 Global Gabapentin Revenue Market Share by Application (2020-2031)
3.2.3 Gabapentin Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Capsule of Gabapentin Revenue Market Share by Application
3.3.2 Tablet of Gabapentin Revenue Market Share by Application
4 Global Gabapentin by Manufacturers
4.1 Global Top Gabapentin Manufacturers by Sales (2020-2025)
4.1.1 Global Gabapentin Sales by Manufacturer (2020-2025)
4.1.2 Global Gabapentin Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Gabapentin Manufacturers by Revenue (2020-2025)
4.2.1 Global Gabapentin Revenue by Manufacturer (2020-2025)
4.2.2 Global Gabapentin Revenue Share by Manufacturer (2020-2025)
4.3 Global Gabapentin Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Gabapentin Manufacturers Covered: Ranking by Revenue
4.4.2 Global Gabapentin Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Gabapentin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Gabapentin Manufacturing Base Distribution, Product Type
4.5.1 Gabapentin Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Gabapentin Market
4.5.3 Manufacturers Gabapentin Product Type and Application
4.5.4 Capsule Market Sales of Gabapentin by Manufacturer
4.5.5 Tablet Market Sales of Gabapentin by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Pfizer
5.1.1 Pfizer Company Information
5.1.2 Pfizer Description, Business Overview
5.1.3 Pfizer Gabapentin Products Offered
5.1.4 Pfizer Gabapentin Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Pfizer Gabapentin Sales by Product in 2024
5.1.6 Pfizer Gabapentin Sales by Application in 2024
5.1.7 Pfizer Gabapentin Sales by Geographic Area in 2024
5.1.8 Pfizer Recent Developments
5.2 Assertio Therapeutics
5.2.1 Assertio Therapeutics Company Information
5.2.2 Assertio Therapeutics Description, Business Overview
5.2.3 Assertio Therapeutics Gabapentin Products Offered
5.2.4 Assertio Therapeutics Gabapentin Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Assertio Therapeutics Gabapentin Sales by Product in 2024
5.2.6 Assertio Therapeutics Gabapentin Sales by Application in 2024
5.2.7 Assertio Therapeutics Gabapentin Sales by Geographic Area in 2024
5.2.8 Assertio Therapeutics Recent Developments
5.3 TEVA
5.3.1 TEVA Company Information
5.3.2 TEVA Description, Business Overview
5.3.3 TEVA Gabapentin Products Offered
5.3.4 TEVA Gabapentin Sales, Revenue and Gross Margin (2020-2025)
5.3.5 TEVA Gabapentin Sales by Product in 2024
5.3.6 TEVA Gabapentin Sales by Application in 2024
5.3.7 TEVA Gabapentin Sales by Geographic Area in 2024
5.3.8 TEVA Recent Developments
5.4 Mylan
5.4.1 Mylan Company Information
5.4.2 Mylan Description, Business Overview
5.4.3 Mylan Gabapentin Products Offered
5.4.4 Mylan Gabapentin Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Mylan Gabapentin Sales by Product in 2024
5.4.6 Mylan Gabapentin Sales by Application in 2024
5.4.7 Mylan Gabapentin Sales by Geographic Area in 2024
5.4.8 Mylan Recent Developments
5.5 Arbor Pharma
5.5.1 Arbor Pharma Company Information
5.5.2 Arbor Pharma Description, Business Overview
5.5.3 Arbor Pharma Gabapentin Products Offered
5.5.4 Arbor Pharma Gabapentin Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Arbor Pharma Gabapentin Sales by Product in 2024
5.5.6 Arbor Pharma Gabapentin Sales by Application in 2024
5.5.7 Arbor Pharma Gabapentin Sales by Geographic Area in 2024
5.5.8 Arbor Pharma Recent Developments
5.6 Novartis
5.6.1 Novartis Company Information
5.6.2 Novartis Description, Business Overview
5.6.3 Novartis Gabapentin Products Offered
5.6.4 Novartis Gabapentin Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Novartis Gabapentin Sales by Product in 2024
5.6.6 Novartis Gabapentin Sales by Application in 2024
5.6.7 Novartis Gabapentin Sales by Geographic Area in 2024
5.6.8 Novartis Recent Developments
5.7 Apotex
5.7.1 Apotex Company Information
5.7.2 Apotex Description, Business Overview
5.7.3 Apotex Gabapentin Products Offered
5.7.4 Apotex Gabapentin Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Apotex Gabapentin Sales by Product in 2024
5.7.6 Apotex Gabapentin Sales by Application in 2024
5.7.7 Apotex Gabapentin Sales by Geographic Area in 2024
5.7.8 Apotex Recent Developments
5.8 Sun Pharmaceutical
5.8.1 Sun Pharmaceutical Company Information
5.8.2 Sun Pharmaceutical Description, Business Overview
5.8.3 Sun Pharmaceutical Gabapentin Products Offered
5.8.4 Sun Pharmaceutical Gabapentin Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Sun Pharmaceutical Gabapentin Sales by Product in 2024
5.8.6 Sun Pharmaceutical Gabapentin Sales by Application in 2024
5.8.7 Sun Pharmaceutical Gabapentin Sales by Geographic Area in 2024
5.8.8 Sun Pharmaceutical Recent Developments
5.9 Aurobindo Pharma
5.9.1 Aurobindo Pharma Company Information
5.9.2 Aurobindo Pharma Description, Business Overview
5.9.3 Aurobindo Pharma Gabapentin Products Offered
5.9.4 Aurobindo Pharma Gabapentin Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Aurobindo Pharma Gabapentin Sales by Product in 2024
5.9.6 Aurobindo Pharma Gabapentin Sales by Application in 2024
5.9.7 Aurobindo Pharma Gabapentin Sales by Geographic Area in 2024
5.9.8 Aurobindo Pharma Recent Developments
5.10 Intas
5.10.1 Intas Company Information
5.10.2 Intas Description, Business Overview
5.10.3 Intas Gabapentin Products Offered
5.10.4 Intas Gabapentin Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Intas Gabapentin Sales by Product in 2024
5.10.6 Intas Gabapentin Sales by Application in 2024
5.10.7 Intas Gabapentin Sales by Geographic Area in 2024
5.10.8 Intas Recent Developments
5.11 Amneal
5.11.1 Amneal Company Information
5.11.2 Amneal Description, Business Overview
5.11.3 Amneal Gabapentin Products Offered
5.11.4 Amneal Gabapentin Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Amneal Gabapentin Sales by Product in 2024
5.11.6 Amneal Gabapentin Sales by Application in 2024
5.11.7 Amneal Gabapentin Sales by Geographic Area in 2024
5.11.8 Amneal Recent Developments
5.12 Marksans Pharma
5.12.1 Marksans Pharma Company Information
5.12.2 Marksans Pharma Description, Business Overview
5.12.3 Marksans Pharma Gabapentin Products Offered
5.12.4 Marksans Pharma Gabapentin Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Marksans Pharma Gabapentin Sales by Product in 2024
5.12.6 Marksans Pharma Gabapentin Sales by Application in 2024
5.12.7 Marksans Pharma Gabapentin Sales by Geographic Area in 2024
5.12.8 Marksans Pharma Recent Developments
5.13 Glenmark
5.13.1 Glenmark Company Information
5.13.2 Glenmark Description, Business Overview
5.13.3 Glenmark Gabapentin Products Offered
5.13.4 Glenmark Gabapentin Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Glenmark Gabapentin Sales by Product in 2024
5.13.6 Glenmark Gabapentin Sales by Application in 2024
5.13.7 Glenmark Gabapentin Sales by Geographic Area in 2024
5.13.8 Glenmark Recent Developments
5.14 Alkem
5.14.1 Alkem Company Information
5.14.2 Alkem Description, Business Overview
5.14.3 Alkem Gabapentin Products Offered
5.14.4 Alkem Gabapentin Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Alkem Gabapentin Sales by Product in 2024
5.14.6 Alkem Gabapentin Sales by Application in 2024
5.14.7 Alkem Gabapentin Sales by Geographic Area in 2024
5.14.8 Alkem Recent Developments
5.15 Jiangsu Enhua
5.15.1 Jiangsu Enhua Company Information
5.15.2 Jiangsu Enhua Description, Business Overview
5.15.3 Jiangsu Enhua Gabapentin Products Offered
5.15.4 Jiangsu Enhua Gabapentin Sales, Revenue and Gross Margin (2020-2025)
5.15.5 Jiangsu Enhua Gabapentin Sales by Product in 2024
5.15.6 Jiangsu Enhua Gabapentin Sales by Application in 2024
5.15.7 Jiangsu Enhua Gabapentin Sales by Geographic Area in 2024
5.15.8 Jiangsu Enhua Recent Developments
5.16 Jiangsu Hengrui
5.16.1 Jiangsu Hengrui Company Information
5.16.2 Jiangsu Hengrui Description, Business Overview
5.16.3 Jiangsu Hengrui Gabapentin Products Offered
5.16.4 Jiangsu Hengrui Gabapentin Sales, Revenue and Gross Margin (2020-2025)
5.16.5 Jiangsu Hengrui Gabapentin Sales by Product in 2024
5.16.6 Jiangsu Hengrui Gabapentin Sales by Application in 2024
5.16.7 Jiangsu Hengrui Gabapentin Sales by Geographic Area in 2024
5.16.8 Jiangsu Hengrui Recent Developments
5.17 Sailike
5.17.1 Sailike Company Information
5.17.2 Sailike Description, Business Overview
5.17.3 Sailike Gabapentin Products Offered
5.17.4 Sailike Gabapentin Sales, Revenue and Gross Margin (2020-2025)
5.17.5 Sailike Gabapentin Sales by Product in 2024
5.17.6 Sailike Gabapentin Sales by Application in 2024
5.17.7 Sailike Gabapentin Sales by Geographic Area in 2024
5.17.8 Sailike Recent Developments
6 North America
6.1 North America Gabapentin Market Size YoY Growth 2020-2031
6.2 North America Gabapentin Market Facts & Figures by Country
6.2.1 North America Gabapentin Sales by Country (2020-2031)
6.2.2 North America Gabapentin Revenue by Country (2020-2031)
6.3 North America Gabapentin Sales by Type (2020-2025)
6.4 North America Gabapentin Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Gabapentin Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Gabapentin Market Facts & Figures by Region
7.2.1 Asia-Pacific Gabapentin Sales by Region (2020-2031)
7.2.2 Asia-Pacific Gabapentin Revenue by Region (2020-2031)
7.3 Asia-Pacific Gabapentin Sales by Type (2020-2025)
7.4 Asia-Pacific Gabapentin Sales by Application (2020-2025)
8 Europe
8.1 Europe Gabapentin Market Size YoY Growth 2020-2031
8.2 Europe Gabapentin Market Facts & Figures by Country
8.2.1 Europe Gabapentin Sales by Country (2020-2031)
8.2.2 Europe Gabapentin Revenue by Country (2020-2031)
8.3 Europe Gabapentin Sales by Type (2020-2025)
8.4 Europe Gabapentin Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Gabapentin Market Size YoY Growth 2020-2031
9.2 Latin America Gabapentin Market Facts & Figures by Country
9.2.1 Latin America Gabapentin Sales by Country (2020-2031)
9.2.2 Latin America Gabapentin Revenue by Country (2020-2031)
9.3 Latin America Gabapentin Sales by Type (2020-2025)
9.4 Latin America Gabapentin Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Gabapentin Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Gabapentin Market Facts & Figures by Country
10.2.1 Middle East and Africa Gabapentin Sales by Country (2020-2031)
10.2.2 Middle East and Africa Gabapentin Revenue by Country (2020-2031)
10.3 Middle East and Africa Gabapentin Sales by Type (2020-2025)
10.4 Middle East and Africa Gabapentin Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Gabapentin Supply Chain Analysis
11.2 Gabapentin Key Raw Materials and Upstream Suppliers
11.3 Gabapentin Clients Analysis
11.4 Gabapentin Sales Channel and Sales Model Analysis
11.4.1 Gabapentin Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Gabapentin Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Gabapentin Distributors
12 Gabapentin Market Dynamics
12.1 Gabapentin Industry Trends
12.2 Gabapentin Market Drivers
12.3 Gabapentin Market Challenges
12.4 Gabapentin Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
TEVA
Mylan NV
Arbor Pharma
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Glenmark
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike
Assertio Therapeutics
List of Tables
 Table 1. Global Gabapentin Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Gabapentin Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Gabapentin Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Gabapentin Sales by Region (2020-2025) & (M Unit)
 Table 5. Global Gabapentin Sales Forecast by Region (2026-2031) & (M Unit)
 Table 6. Global Gabapentin Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Gabapentin Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Gabapentin Sales Volume by Type (2020-2025) & (M Unit)
 Table 9. Global Gabapentin Sales Volume by Type (2026-2031) & (M Unit)
 Table 10. Global Gabapentin Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Gabapentin Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Gabapentin Sales Volume by Application (2020-2025) & (M Unit)
 Table 13. Global Gabapentin Sales Volume by Application (2026-2031) & (M Unit)
 Table 14. Global Gabapentin Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Gabapentin Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Gabapentin Sales by Manufacturer (2020-2025) & (M Unit)
 Table 17. Global Gabapentin Sales Share by Manufacturer (2020-2025)
 Table 18. Gabapentin Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Gabapentin Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Gabapentin Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top Gabapentin Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Gabapentin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Gabapentin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin as of 2024)
 Table 24. Gabapentin Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Gabapentin Market
 Table 26. Manufacturers Gabapentin Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Pfizer Company Information
 Table 29. Pfizer Description and Business Overview
 Table 30. Pfizer Gabapentin Product
 Table 31. Pfizer Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Pfizer Sales Proportion of Gabapentin by Product in 2024
 Table 33. Pfizer Sales Proportion of Gabapentin by Application in 2024
 Table 34. Pfizer Sales Proportion of Gabapentin by Geographic Area in 2024
 Table 35. Pfizer Recent Developments
 Table 36. Assertio Therapeutics Company Information
 Table 37. Assertio Therapeutics Description and Business Overview
 Table 38. Assertio Therapeutics Gabapentin Product
 Table 39. Assertio Therapeutics Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. Assertio Therapeutics Sales Proportion of Gabapentin by Product in 2024
 Table 41. Assertio Therapeutics Sales Proportion of Gabapentin by Application in 2024
 Table 42. Assertio Therapeutics Sales Proportion of Gabapentin by Geographic Area in 2024
 Table 43. Assertio Therapeutics Recent Developments
 Table 44. TEVA Company Information
 Table 45. TEVA Description and Business Overview
 Table 46. TEVA Gabapentin Product
 Table 47. TEVA Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. TEVA Sales Proportion of Gabapentin by Product in 2024
 Table 49. TEVA Sales Proportion of Gabapentin by Application in 2024
 Table 50. TEVA Sales Proportion of Gabapentin by Geographic Area in 2024
 Table 51. TEVA Recent Developments
 Table 52. Mylan Company Information
 Table 53. Mylan Description and Business Overview
 Table 54. Mylan Gabapentin Product
 Table 55. Mylan Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. Mylan Sales Proportion of Gabapentin by Product in 2024
 Table 57. Mylan Sales Proportion of Gabapentin by Application in 2024
 Table 58. Mylan Sales Proportion of Gabapentin by Geographic Area in 2024
 Table 59. Mylan Recent Developments
 Table 60. Arbor Pharma Company Information
 Table 61. Arbor Pharma Description and Business Overview
 Table 62. Arbor Pharma Gabapentin Product
 Table 63. Arbor Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Arbor Pharma Sales Proportion of Gabapentin by Product in 2024
 Table 65. Arbor Pharma Sales Proportion of Gabapentin by Application in 2024
 Table 66. Arbor Pharma Sales Proportion of Gabapentin by Geographic Area in 2024
 Table 67. Arbor Pharma Recent Developments
 Table 68. Novartis Company Information
 Table 69. Novartis Description and Business Overview
 Table 70. Novartis Gabapentin Product
 Table 71. Novartis Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. Novartis Sales Proportion of Gabapentin by Product in 2024
 Table 73. Novartis Sales Proportion of Gabapentin by Application in 2024
 Table 74. Novartis Sales Proportion of Gabapentin by Geographic Area in 2024
 Table 75. Novartis Recent Developments
 Table 76. Apotex Company Information
 Table 77. Apotex Description and Business Overview
 Table 78. Apotex Gabapentin Product
 Table 79. Apotex Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. Apotex Sales Proportion of Gabapentin by Product in 2024
 Table 81. Apotex Sales Proportion of Gabapentin by Application in 2024
 Table 82. Apotex Sales Proportion of Gabapentin by Geographic Area in 2024
 Table 83. Apotex Recent Developments
 Table 84. Sun Pharmaceutical Company Information
 Table 85. Sun Pharmaceutical Description and Business Overview
 Table 86. Sun Pharmaceutical Gabapentin Product
 Table 87. Sun Pharmaceutical Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Sun Pharmaceutical Sales Proportion of Gabapentin by Product in 2024
 Table 89. Sun Pharmaceutical Sales Proportion of Gabapentin by Application in 2024
 Table 90. Sun Pharmaceutical Sales Proportion of Gabapentin by Geographic Area in 2024
 Table 91. Sun Pharmaceutical Recent Developments
 Table 92. Aurobindo Pharma Company Information
 Table 93. Aurobindo Pharma Description and Business Overview
 Table 94. Aurobindo Pharma Gabapentin Product
 Table 95. Aurobindo Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 96. Aurobindo Pharma Sales Proportion of Gabapentin by Product in 2024
 Table 97. Aurobindo Pharma Sales Proportion of Gabapentin by Application in 2024
 Table 98. Aurobindo Pharma Sales Proportion of Gabapentin by Geographic Area in 2024
 Table 99. Aurobindo Pharma Recent Developments
 Table 100. Intas Company Information
 Table 101. Intas Description and Business Overview
 Table 102. Intas Gabapentin Product
 Table 103. Intas Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 104. Intas Sales Proportion of Gabapentin by Product in 2024
 Table 105. Intas Sales Proportion of Gabapentin by Application in 2024
 Table 106. Intas Sales Proportion of Gabapentin by Geographic Area in 2024
 Table 107. Intas Recent Developments
 Table 108. Amneal Company Information
 Table 109. Amneal Description and Business Overview
 Table 110. Amneal Gabapentin Product
 Table 111. Amneal Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 112. Amneal Sales Proportion of Gabapentin by Product in 2024
 Table 113. Amneal Sales Proportion of Gabapentin by Application in 2024
 Table 114. Amneal Sales Proportion of Gabapentin by Geographic Area in 2024
 Table 115. Amneal Recent Developments
 Table 116. Marksans Pharma Company Information
 Table 117. Marksans Pharma Description and Business Overview
 Table 118. Marksans Pharma Gabapentin Product
 Table 119. Marksans Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 120. Marksans Pharma Sales Proportion of Gabapentin by Product in 2024
 Table 121. Marksans Pharma Sales Proportion of Gabapentin by Application in 2024
 Table 122. Marksans Pharma Sales Proportion of Gabapentin by Geographic Area in 2024
 Table 123. Marksans Pharma Recent Developments
 Table 124. Glenmark Company Information
 Table 125. Glenmark Description and Business Overview
 Table 126. Glenmark Gabapentin Product
 Table 127. Glenmark Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Glenmark Sales Proportion of Gabapentin by Product in 2024
 Table 129. Glenmark Sales Proportion of Gabapentin by Application in 2024
 Table 130. Glenmark Sales Proportion of Gabapentin by Geographic Area in 2024
 Table 131. Glenmark Recent Developments
 Table 132. Alkem Company Information
 Table 133. Alkem Description and Business Overview
 Table 134. Alkem Gabapentin Product
 Table 135. Alkem Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 136. Alkem Sales Proportion of Gabapentin by Product in 2024
 Table 137. Alkem Sales Proportion of Gabapentin by Application in 2024
 Table 138. Alkem Sales Proportion of Gabapentin by Geographic Area in 2024
 Table 139. Alkem Recent Developments
 Table 140. Jiangsu Enhua Company Information
 Table 141. Jiangsu Enhua Description and Business Overview
 Table 142. Jiangsu Enhua Gabapentin Product
 Table 143. Jiangsu Enhua Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 144. Jiangsu Enhua Sales Proportion of Gabapentin by Product in 2024
 Table 145. Jiangsu Enhua Sales Proportion of Gabapentin by Application in 2024
 Table 146. Jiangsu Enhua Sales Proportion of Gabapentin by Geographic Area in 2024
 Table 147. Jiangsu Enhua Recent Developments
 Table 148. Jiangsu Hengrui Company Information
 Table 149. Jiangsu Hengrui Description and Business Overview
 Table 150. Jiangsu Hengrui Gabapentin Product
 Table 151. Jiangsu Hengrui Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 152. Jiangsu Hengrui Sales Proportion of Gabapentin by Product in 2024
 Table 153. Jiangsu Hengrui Sales Proportion of Gabapentin by Application in 2024
 Table 154. Jiangsu Hengrui Sales Proportion of Gabapentin by Geographic Area in 2024
 Table 155. Jiangsu Hengrui Recent Developments
 Table 156. Sailike Company Information
 Table 157. Sailike Description and Business Overview
 Table 158. Sailike Gabapentin Product
 Table 159. Sailike Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 160. Sailike Sales Proportion of Gabapentin by Product in 2024
 Table 161. Sailike Sales Proportion of Gabapentin by Application in 2024
 Table 162. Sailike Sales Proportion of Gabapentin by Geographic Area in 2024
 Table 163. Sailike Recent Developments
 Table 164. North America Gabapentin Sales by Country (2020-2025) & (M Unit)
 Table 165. North America Gabapentin Sales by Country (2026-2031) & (M Unit)
 Table 166. North America Gabapentin Revenue by Country (2020-2025) & (US$ Million)
 Table 167. North America Gabapentin Revenue by Country (2026-2031) & (US$ Million)
 Table 168. North America Gabapentin Sales by Type (2020-2025) & (M Unit)
 Table 169. North America Gabapentin Sales by Application (2020-2025) & (M Unit)
 Table 170. Asia-Pacific Gabapentin Sales by Region (2020-2025) & (M Unit)
 Table 171. Asia-Pacific Gabapentin Sales by Region (2026-2031) & (M Unit)
 Table 172. Asia-Pacific Gabapentin Revenue by Region (2020-2025) & (US$ Million)
 Table 173. Asia-Pacific Gabapentin Revenue by Region (2026-2031) & (US$ Million)
 Table 174. Asia-Pacific Gabapentin Sales by Type (2020-2025) & (M Unit)
 Table 175. Asia-Pacific Gabapentin Sales by Application (2020-2025) & (M Unit)
 Table 176. Europe Gabapentin Sales by Country (2020-2025) & (M Unit)
 Table 177. Europe Gabapentin Sales by Country (2026-2031) & (M Unit)
 Table 178. Europe Gabapentin Revenue by Country (2020-2025) & (US$ Million)
 Table 179. Europe Gabapentin Revenue by Country (2026-2031) & (US$ Million)
 Table 180. Europe Gabapentin Sales by Type (2020-2025) & (M Unit)
 Table 181. Europe Gabapentin Sales by Application (2020-2025) & (M Unit)
 Table 182. Latin America Gabapentin Sales by Country (2020-2025) & (M Unit)
 Table 183. Latin America Gabapentin Sales by Country (2026-2031) & (M Unit)
 Table 184. Latin America Gabapentin Revenue by Country (2020-2025) & (US$ Million)
 Table 185. Latin America Gabapentin Revenue by Country (2026-2031) & (US$ Million)
 Table 186. Latin America Gabapentin Sales by Type (2020-2025) & (M Unit)
 Table 187. Latin America Gabapentin Sales by Application (2020-2025) & (M Unit)
 Table 188. Middle East and Africa Gabapentin Sales by Country (2020-2025) & (M Unit)
 Table 189. Middle East and Africa Gabapentin Sales by Country (2026-2031) & (M Unit)
 Table 190. Middle East and Africa Gabapentin Revenue by Country (2020-2025) & (US$ Million)
 Table 191. Middle East and Africa Gabapentin Revenue by Country (2026-2031) & (US$ Million)
 Table 192. Middle East and Africa Gabapentin Sales by Type (2020-2025) & (M Unit)
 Table 193. Middle East and Africa Gabapentin Sales by Application (2020-2025) & (M Unit)
 Table 194. Gabapentin Key Raw Materials, Industry Status and Trend
 Table 195. Gabapentin Key Raw Materials and Upstream Suppliers
 Table 196. Gabapentin Clients Status and Trend
 Table 197. Gabapentin Typical Clients
 Table 198. Gabapentin Distributors
 Table 199. Gabapentin Market Trends
 Table 200. Gabapentin Market Drivers
 Table 201. Gabapentin Market Challenges
 Table 202. Gabapentin Market Restraints
 Table 203. Research Programs/Design for This Report
 Table 204. Key Data Information from Secondary Sources
 Table 205. Key Data Information from Primary Sources
 Table 206. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Gabapentin Product Picture
 Figure 2. Global Gabapentin Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Gabapentin Sales Market Share by Type in 2024 & 2031
 Figure 4. Capsule Product Picture
 Figure 5. Tablet Product Picture
 Figure 6. Global Gabapentin Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Gabapentin Sales Market Share by Application in 2024 & 2031
 Figure 8. Epilepsy
 Figure 9. Neuropathic Pain
 Figure 10. Restless Legs Syndrome
 Figure 11. Others
 Figure 12. Gabapentin Report Years Considered
 Figure 13. Global Gabapentin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Gabapentin Market Size 2020-2031 (US$ Million)
 Figure 15. Global Gabapentin Sales 2020-2031 (M Unit)
 Figure 16. Global Gabapentin Sales Market Share Forecast by Region (2020-2031)
 Figure 17. Global Gabapentin Revenue Market Share by Region (2020-2031)
 Figure 18. Global Gabapentin Sales Market Share Forecast by Type (2020-2031)
 Figure 19. Global Gabapentin Revenue Market Share Forecast by Type (2020-2031)
 Figure 20. Gabapentin Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 21. Global Gabapentin Sales Market Share Forecast by Application (2020-2031)
 Figure 22. Global Gabapentin Revenue Market Share Forecast by Application (2020-2031)
 Figure 23. Gabapentin Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 24. Capsule of Gabapentin Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Tablet of Gabapentin Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Global Gabapentin Sales Share by Manufacturer in 2024
 Figure 27. Gabapentin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 28. Capsule Market Sales Proportion by Manufacturer in 2024
 Figure 29. Tablet Market Sales Proportion by Manufacturer in 2024
 Figure 30. North America Gabapentin Revenue 2020-2031 (US$ Million)
 Figure 31. North America Gabapentin Sales Market Share by Type (2020-2025)
 Figure 32. North America Gabapentin Sales Market Share by Application (2020-2025)
 Figure 33. Asia-Pacific Gabapentin Revenue 2020-2031 (US$ Million)
 Figure 34. Asia-Pacific Gabapentin Sales Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific Gabapentin Revenue Market Share by Region (2020-2031)
 Figure 36. Asia-Pacific Gabapentin Sales Market Share by Type (2020-2025)
 Figure 37. Asia-Pacific Gabapentin Sales Market Share by Application (2020-2025)
 Figure 38. Europe Gabapentin Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 39. Europe Gabapentin Sales Market Share by Country (2020-2031)
 Figure 40. Europe Gabapentin Revenue Market Share by Country (2020-2031)
 Figure 41. Europe Gabapentin Sales Market Share by Type (2020-2025)
 Figure 42. Europe Gabapentin Sales Market Share by Application (2020-2025)
 Figure 43. Latin America Gabapentin Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 44. Latin America Gabapentin Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Gabapentin Revenue Market Share by Country (2020-2025)
 Figure 46. Latin America Gabapentin Sales Market Share by Type (2020-2025)
 Figure 47. Latin America Gabapentin Sales Market Share by Application (2020-2025)
 Figure 48. Middle East and Africa Gabapentin Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 49. Middle East and Africa Gabapentin Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Gabapentin Revenue Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Gabapentin Sales Market Share by Type (2020-2025)
 Figure 52. Middle East and Africa Gabapentin Sales Market Share by Application (2020-2025)
 Figure 53. Gabapentin Supply Chain (Upstream and Downstream Market)
 Figure 54. Global Production Market Share of Gabapentin Raw Materials by Region in 2024
 Figure 55. Gabapentin Distribution Channels
 Figure 56. Global Gabapentin Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 57. Global Gabapentin Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Gabapentin Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pregabalin Market Insights Forecast to 2030
Global Gabapentin Enacarbil Market Research Report 2024
Pregabalin Capsule Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gabapentin API Market Research Report 2024
Epilepsy Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vigabatrin Market Research Report 2024
Zonisamide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rufinamide Market Insights Forecast to 2030
Oxcarbazepine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Primidone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Epilepsy Treatment Drug Market Research Report 2024
Global Valpromide Market Research Report 2024
Global Nervous System Chemicals Market Research Report 2024
Global Neuropathic Pain Drugs Market Research Report 2024
Global Felbamate Market Research Report 2024
Anti Epilepsy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nortriptyline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cyclobenzaprine Drug Market Insights Forecast to 2030
Global Epileptic Seizures Treatment Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions